Part 1—Jason Aldred, MD: Understanding Possible Side Effects When Treating Patients with Parkinson’s Disease

Dr. Jason Aldred, owner of Selkirk Neurology in Spokane, WA, discusses the safety profile of Vyalev (foscarbidopa/foslevodopa), notably injection site reactions and skin considerations.

Click here to view Part 2, where Dr. Aldred discusses neuropsychiatric effects and dyskinesia that patients may experience when taking Vyalev.

MORE EXPERT PERSPECTIVES IN PARKINSON'S DISEASE:

Part 2—Jason Aldred, MD: Understanding Possible Side Effects When Treating Patients with Parkinson’s Disease

Dr. Jason Aldred, owner of Selkirk Neurology in Spokane, WA, discusses the neuropsychiatric effects and dyskinesia that patients may experience when taking Vyalev (foscarbidopa/foslevodopa).

Exploring Advancements in the Treatment Landscape for Patients with Parkinson’s Disease

Dr. Robert Hauser, from the University of South Florida, provides an overview of Vyalev (foscarbidopa/foslevodopa), highlighting medication administration and mechanism of action, as well as phase 3 trial findings.